相关实验视频

Updated: Jun 16, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

在患有原发性膜性脏病患者的初始或二线治疗中使用奥比努祖马布

Xiaole Su^1,2,3, Binxin Wu^1,2,3, Xuan Tie^1,2,3

¹Department of Nephrology, Second Hospital of Shanxi Medical University, Taiyuan, China.

Kidney international reports

|August 19, 2024

概括

奥比努祖马布通过减少蛋白尿,有效地治疗膜性病 (MN),当作为初始治疗时,缓解率更高. 这种针对B细胞的治疗是安全的,并且在MN患者中耐受良好.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

B细胞淋巴细胞与膜性病变 (MN) 的病原发生有关.
准B细胞为MN提供了一个潜在的治疗策略.

研究的目的:

评估Obinutuzumab的疗效和安全性,一种抗CD20单克隆抗体,在患有初级MN的患者中.
为了比较Obinutuzumab作为初始与二线治疗的有效性.

主要方法:

对接受Obinutuzumab的59名初级MN患者的回顾性分析.
主要结局:蛋白尿的完全或部分缓解.
随访时间至少为6个月.

主要成果:

84.7%的患者实现了完全或部分缓解.
当Obinutuzumab作为初始疗法使用时,缓解率显著更高 (调整HR,4.5;P<0.001).
观察到B细胞,抗PLA2R抗体和蛋白尿的减少,血清白蛋白增加. 没有报告严重不良事件.

结论:

奥比努图祖马布是一种有前途的,耐受性良好的初级MN治疗方法.
使用Obinutuzumab的初始治疗表明在实现缓解方面具有卓越的疗效.

关键词:

这就是Obinutuzumab.反CD20单克隆抗体的抗体.抗脂酶A2受体抗体慢性脏疾病慢性脏疾病膜性脏病是一种膜性脏病.蛋白质尿症是一种蛋白质尿症.

更多相关视频

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...